GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » SenesTech Inc (NAS:SNES) » Definitions » EBIT

SenesTech (SenesTech) EBIT : $-7.50 Mil (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is SenesTech EBIT?

SenesTech's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was $-1.83 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was $-7.50 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. SenesTech's annualized ROC % for the quarter that ended in Mar. 2024 was -446.79%. SenesTech's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -540.43%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. SenesTech's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -1,279.35%.


SenesTech EBIT Historical Data

The historical data trend for SenesTech's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SenesTech EBIT Chart

SenesTech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.98 -7.91 -8.26 -9.69 -7.71

SenesTech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.04 -1.99 -1.95 -1.73 -1.83

Competitive Comparison of SenesTech's EBIT

For the Specialty Chemicals subindustry, SenesTech's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SenesTech's EV-to-EBIT Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, SenesTech's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where SenesTech's EV-to-EBIT falls into.



SenesTech EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.50 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SenesTech  (NAS:SNES) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

SenesTech's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=-7.372 * ( 1 - 0% )/( (1.612 + 1.688)/ 2 )
=-7.372/1.65
=-446.79 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

SenesTech's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-7.312/( ( (0.598 + max(0.742, 0)) + (0.507 + max(0.859, 0)) )/ 2 )
=-7.312/( ( 1.34 + 1.366 )/ 2 )
=-7.312/1.353
=-540.43 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.095 + 0.795 + 0.388) - (0.286 + 0.018 + 0.232)
=0.742

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.161 + 0.874 + 0.346) - (0.222 + 0.015 + 0.285)
=0.859

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

SenesTech's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2024 )
=-7.497/0.586
=-1,279.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SenesTech EBIT Related Terms

Thank you for viewing the detailed overview of SenesTech's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


SenesTech (SenesTech) Business Description

Traded in Other Exchanges
N/A
Address
23460 N 19th Avenue, Suite 110, Phoenix, AZ, USA, 85027
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets.
Executives
Joel Lee Fruendt director, officer: Chief Executive Officer C/O SENESTECH, INC., 23460 N. 19TH AVE., STE 110, PHOENIX AZ 85027
Grandinetti Phillip Nicholas Iii director 23460 N. 19TH AVE SUITE 110, PHOENIX AZ 85027
Kathleen Claire Kavanagh director 23460 N. 19TH AVE SUITE 110, PHOENIX AZ 85027
Jamie Bechtel Morrison director 3140 N. CADEN COURT SUITE 1, FLAGSTAFF AZ 86004
Jacob Steven Leach director 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Delphine Francois Chiavarini director 3140 N. CADEN COURT SUITE 1, FLAGSTAFF AZ 86004
Kenneth S Siegel director, officer: Chief Executive Officer 40 STARWOOD HOTELS & RESORTS, 111 WESTCHESTER AVE, WHITE PLAINS NY 10604
Nicole C Williams officer: Chief Strategy Officer 23460 N 19TH AVE SUITE 110, PHOENIX AZ 85027
Steven C. Krause officer: EVP, Sales and Marketing 23460 N. 19TH AVE STE 110, PHOENIX AZ 85027
Loretta Powers Mayer director, 10 percent owner, officer: CEO & Chief Scientific Officer C/O SENESTECH, INC., 3140 N. CADEN COURT, SUITE 1, FLAGSTAFF AZ 86004
Cheryl Ann Dyer director, 10 percent owner, officer: Pres. & Chief Research Officer C/O SENESTECH, INC., 3140 N. CADEN COURT, SUITE 1, FLAGSTAFF AZ 86004
Edward Albe officer: SVP of Commercialization 3140 N. CADEN COURT SUITE 1, FLAGSTAFF AZ 96004
Julia Ann Williams director C/O SENESTECH, INC., 3140 N. CADEN COURT, SUITE 1, FLAGSTAFF AZ 86004
Andrew Altman officer: Chief Operating Officer C/O SENESTECH, INC., 3140 N. CADEN COURT, SUITE 1, FLAGSTAFF AZ 86004
Grover T Wickersham director, officer: Vice Chairman 430 CAMBRIDGE AVENUE, SUITE 100, PALO ALTO CA 94306